--- title: "U.S. stock market quick update: Q2 massive loss of $89.07 million, CEO plans to retire, Accendra Health down 13.21%" type: "News" locale: "en" url: "https://longbridge.com/en/news/295559620.md" description: "Accendra Health fell 13.21%; Cardinal Health rose 0.44%, with a transaction volume of USD 338 million; McKesson rose 1.19%, with a transaction volume of USD 223 million; Cencora rose 1.29%, with a transaction volume of USD 999.1 million; Henry Schein rose 1.19%, with a market value of USD 9.933 billion" datetime: "2026-08-11T16:13:21.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295559620.md) - [en](https://longbridge.com/en/news/295559620.md) - [zh-HK](https://longbridge.com/zh-HK/news/295559620.md) generator: "portal-rs" --- # U.S. stock market quick update: Q2 massive loss of $89.07 million, CEO plans to retire, Accendra Health down 13.21% **U.S. Stock Market Midday Update** Accendra Health fell 13.21%. Based on recent key news: 1. On August 10, Accendra Health announced its second-quarter financial report, with a net income loss of $89.07 million, and revenue below market expectations, leading to a significant drop in stock price. Source: Reuters 2. On August 10, the company announced that CEO Edward A. Pesicka plans to retire by the end of 2026, and the search for a successor has begun, raising market concerns about the stability of the company's future leadership. Source: Reuters 3. On August 10, the company completed the divestiture of its main business and optimized its balance sheet. Despite a reduction in debt, the market remains skeptical about the stability of its future performance. Source: Accendra Health, Inc. **Top Stocks by Industry Trading Volume** Cardinal Health rose 0.44%. Based on recent key news: 1. On August 11, Cardinal Health's fiscal year 2027 earnings guidance exceeded Wall Street expectations, driving the stock price up. The company expects adjusted earnings per share to grow by 13% to 15%, significantly higher than market expectations, resulting in a 52-week high for the stock price; 2. On August 11, Cardinal Health reported adjusted earnings per share of $2.91 for the fourth quarter, surpassing analysts' expectations of $2.42. Although quarterly revenue was slightly below expectations, strong earnings performance boosted market confidence; 3. On August 11, analysts maintained a "Buy" rating on Cardinal Health and raised the target price to $257.62, reflecting market optimism about the company's future growth. The pharmaceutical distribution industry shows strong demand, but risks need to be monitored. McKesson rose 1.19%. Based on recent key news: 1. On August 11, Citigroup analyst Daniel Grosslight reiterated a Buy rating on McKesson and set a target price of $1,000. This move boosted market confidence in McKesson, driving the stock price up. 2. On August 10, McKesson disclosed the stock holdings of executive Ramesh Srinivasan through the EDGAR system, indicating internal confidence in the company's future development, further supporting the stock price increase. 3. On August 7, Morgan Stanley analyst Erin Wright also gave McKesson a Buy rating, further solidifying market expectations for the stock. The healthcare sector has performed strongly recently, with significant capital inflows. Cencora rose 1.29%, with a trading volume of $99.91 million, reaching a 60-day high, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, this stock shows significant volatility, and specific reasons need further observation **Stocks Ranked Among the Top in Market Capitalization** Henry Schein, up 1.19%, with a market capitalization of $9.933 billion, trading volume increased, and no significant news recently. The trading is active, with clear capital flow. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation ### Related Stocks - [ACH.US](https://longbridge.com/en/quote/ACH.US.md) - [CAH.US](https://longbridge.com/en/quote/CAH.US.md) - [MCK.US](https://longbridge.com/en/quote/MCK.US.md) - [COR.US](https://longbridge.com/en/quote/COR.US.md) - [HSIC.US](https://longbridge.com/en/quote/HSIC.US.md) ## Related News & Research - [McKesson Stock Outlook: Is Wall Street Bullish or Bearish?](https://longbridge.com/en/news/296804236.md) - [D L Carlson Investment Group Inc. Purchases New Shares in McKesson Corporation $MCK](https://longbridge.com/en/news/296587606.md) - [McKesson to buy Precision Medicine Group in about $2.25 billion deal](https://longbridge.com/en/news/296912806.md) - [Paralel Advisors LLC Invests $2.02 Million in McKesson Corporation $MCK](https://longbridge.com/en/news/296604939.md) - [Danica Pension Livsforsikringsaktieselskab Makes New $48.77 Million Investment in McKesson Corporation $MCK](https://longbridge.com/en/news/296323235.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**